Search Results

Canadian Children Six To 17 Years Old Become The First Worldwide To Benefit From A New Biologic Treatment Option Approved For Chronic Inflammatory Bowel Disease

Innovative Medicine

August 26, 2011

NUCYNTA® ER (Tapentadol Extended-Release Tablets) Receives FDA Approval For The Management Of Moderate To Severe Chronic Pain

Clinical Trial Data Demonstrate Efficacy, Safety and Favorable Tolerability

Research

August 4, 2011

Johnson & Johnson Pharmaceutical Research & Development Scientists Uncover Previously Unknown Role For Class Of Molecules

Innovative Medicine

August 3, 2011

Celebrity Chef Sam Talbot Joins “Life First™” Diabetes Awareness Campaign

Talbot Partners With OneTouch® Brand Blood Glucose Monitoring Systems To Help People Learn To Manage Diabetes While Living Life Without Limits

Innovative Medicine

July 28, 2011

Zytiga™* (Abiraterone Acetate) Receives Health Canada Approval For Treatment Of Metastatic Prostate Cancer

First Oral Treatment for Metastatic Prostate Cancer That Inhibits Androgen Production at All Three Sources

Search Results

No Results

Search Results

You are now leaving jnj.com/innovativemedicine